Atomo Diagnostics Ltd.ASX: AT1

Quarterly Activities/Appendix 4C Cash Flow Report

· Issued by Atomo Diagnostics Ltd. via ASX

Filed with ASX ·

ASX Announcement October 29, 2026 Quarterly Activity Report Q1 FY27 Atomo expands and solidifies product pipeline and posts solid revenue growth • Atomo signs agreement for Generation 4 HIV product development program with 1 Innovation Scientific, adding to Atomo’s proprietary product pipeline...

View Attachment

6ix is reading this filing.

Atomo Diagnostics Ltd. on 6ix

In the deck

Earlier from Atomo Diagnostics

Later from Atomo Diagnostics

All Atomo Diagnostics news releases